[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

# ![$tecx Graphic](https://lunarcrush.com/gi/w:26/t:$tecx.png) $tecx

$TECX surges after Oppenheimer initiates coverage with an outperform rating. Users are actively sharing stock recommendations and investment advice, reporting significant gains.

### About $tecx
Tectonic Therapeutic ($TECX) is a financial asset, likely a stock.  

### Insights [#](/topic/$tecx/insights)
- $tecx engagements is up XXXXXX% from the previous week.
- $tecx posts created is up XXX% from the previous week.

### Engagements: XXX [#](/topic/$tecx/interactions)
---
![Engagements Line Chart](https://lunarcrush.com/gi/w:600/t:$tecx/c:line/m:interactions/iv:1d.svg)  
[Engagements 24-Hour Time-Series Raw Data](/topic/$tecx/time-series/interactions.tsv)  
**Current Value**: XXX  
**Daily Average**: XXXXX  
**1 Week**: XXXXXX +254%  
**1 Month**: XXXXXX -XX%  
**1-Year High**: XXXXXX on 2025-07-08  
**1-Year Low**: X on 2025-09-15  

| Social Network | X   |
| -------------- | -   |
| Engagements    | XXX |
  

  
  
### Mentions: XX [#](/topic/$tecx/posts_active)
---
![Mentions Line Chart](https://lunarcrush.com/gi/w:600/t:$tecx/c:line/m:posts_active/iv:1d.svg)  
[Mentions 24-Hour Time-Series Raw Data](/topic/$tecx/time-series/posts_active.tsv)  
**Current Value**: XX  
**Daily Average**: XX  
**1 Month**: XX -XX%  
**1-Year High**: XXX on 2025-06-27  
**1-Year Low**: X on 2025-05-13  

| Social Network | X  |
| -------------- | -  |
| Mentions       | XX |
  

  
  
### Creators: XX [#](/topic/$tecx/contributors_active)
---
![Creators Line Chart](https://lunarcrush.com/gi/w:600/t:$tecx/c:line/m:contributors_active/iv:1d.svg)  
[Creators 24-Hour Time-Series Raw Data](/topic/$tecx/time-series/contributors_active.tsv)  
XX unique social accounts have posts mentioning $tecx in the last XX hours which is up XX% from XX in the previous XX hours
**Daily Average**: XX  
**1 Month**: XX -XX%  
**1-Year High**: XXX on 2025-06-27  
**1-Year Low**: X on 2025-05-13  

The most influential creators that mention $tecx in the last XX hours

| Creator                                | Rank | Followers | Posts | Engagements |
| -------                                | ---- | --------- | ----- | ----------- |
| [@Tickeron](/creator/twitter/Tickeron) | X    | XXXXXX    | X     | XX          |

[View More](/list/creators/$tecx/100)
  
  
### Sentiment: XXX% [#](/topic/$tecx/sentiment)
---
![Sentiment Line Chart](https://lunarcrush.com/gi/w:600/t:$tecx/c:line/m:sentiment/iv:1d.svg)  
[Sentiment 24-Hour Time-Series Raw Data](/topic/$tecx/time-series/sentiment.tsv)  
**Current Value**: XXX%  
**Daily Average**: XX%  
**1 Week**: XXX% no change  
**1 Month**: XXX% no change  
**1-Year High**: XXX% on 2025-04-29  
**1-Year Low**: XX% on 2025-05-19  

**Most Supportive Themes**
- **Positive Sentiment and Stock Recommendations:** (60%) Users are actively sharing stock recommendations and investment advice, reporting significant gains.
- **Coverage Initiation by Oppenheimer:** (20%) Oppenheimer initiated coverage with an outperform rating.
  
**Most Critical Themes**
- **Mentions of other assets:** (10%)  Mentions of other assets may indicate a lack of focus on the primary asset.
- **General Market Discussion:** (10%)  Some posts discuss general market trends and investment strategies, which may dilute the focus on the specific asset.
  
Network engagement breakdown:  
| Network | Positive | %   | Neutral | %   | Negative | %  |
| ------- | -------- | -   | ------- | -   | -------- | -  |
| X       | XXX      | XX% | XXX     | XX% | X        | X% |
|         |          |     |         |     |          |    |
| Total   | XXX      | XX% | XXX     | XX% | X        | X% |
  


**Top assets mentioned**
In the posts about $tecx in the last XX hours

[AstraZeneca PLC (AZN)](/topic/$azn)
[Incyte Corporation (INCY)](/topic/$incy)
[Moderna Inc (MRNA)](/topic/$mrna)
[Merck & Co., Inc. (MRK)](/topic/$mrk)
[DNotes (NOTE)](/topic/dnotes)
[Notional Finance (NOTE)](/topic/note-notional-finance)
[Regeneron Pharmaceuticals Inc (REGN)](/topic/regeneron-pharmaceuticals-inc)
[Exelixis Inc (EXEL)](/topic/$exel)
[BridgeBio Pharma, Inc. Common Stock (BBIO)](/topic/$bbio)
[Crown Holdings, Inc. (CCK)](/topic/$cck)

**Top topics mentioned**
In the posts about $tecx in the last XX hours

[stocks healthcare](/topic/stocks-healthcare), [$azn](/topic/$azn), [$incy](/topic/$incy), [$mrna](/topic/$mrna), [$mrk](/topic/$mrk), [manat](/topic/manat), [$tnfa](/topic/$tnfa), [dnotes](/topic/dnotes), [note notional finance](/topic/note-notional-finance), [coins defi](/topic/coins-defi), [coins lending borrowing](/topic/coins-lending-borrowing), [stocks](/topic/stocks), [regeneron pharmaceuticals inc](/topic/regeneron-pharmaceuticals-inc), [$exel](/topic/$exel), [$bbio](/topic/$bbio), [stocks consumer defensive](/topic/stocks-consumer-defensive), [$cck](/topic/$cck), [$cnr](/topic/$cnr), [$ecl](/topic/$ecl), [stocks consumer cyclical](/topic/stocks-consumer-cyclical), [$rzlt](/topic/$rzlt), [$tcmd](/topic/$tcmd), [$idya](/topic/$idya), [$urgn](/topic/$urgn), [$abeo](/topic/$abeo), [$adag](/topic/$adag), [$cccc](/topic/$cccc), [$vtyx](/topic/$vtyx), [j b hunt transport services inc](/topic/j-b-hunt-transport-services-inc), [stocks industrials](/topic/stocks-industrials), [$jbht](/topic/$jbht), [$rrc](/topic/$rrc), [$hun](/topic/$hun), [investment](/topic/investment), [$tern](/topic/$tern), [$tars](/topic/$tars), [$cnta](/topic/$cnta), [$dnli](/topic/$dnli), [$200m2b](/topic/$200m2b), [$soc](/topic/$soc), [$opal](/topic/$opal), [$kdk](/topic/$kdk), [$mimi](/topic/$mimi), [$bmrn](/topic/$bmrn), [$ajg](/topic/$ajg), [$alks](/topic/$alks), [$aroc](/topic/$aroc)

### Top Social Posts [#](/topic/$tecx/posts)
---
Top posts by engagements in the last XX hours

*Showing only X posts for non-authenticated requests. Use your API key in requests for full results.*

"Like the setup for $TECX as expectations are low heading into the HFrEF + $AZN Re-PHIRE readouts. The primary endpoint for Re-PHIRE is change in PVR vs pbo but w/ the inclusion of ipcPH patients (which have normal PVR) secondary endpoints and subgroups should be more important"  
[X Link](https://x.com/mtheory11bio/status/1978474430461366607) [@mtheory11bio](/creator/x/mtheory11bio) 2025-10-15T14:53Z 5244 followers, 2808 engagements


"$tecx On April X 2025 Mcguire (BoD chair) sold 500k shares at $XXXX. The same day GOAT Timothy Springer bought 500k shares at $17.1"  
[X Link](https://x.com/ValueForAll1/status/1978459002947166516) [@ValueForAll1](/creator/x/ValueForAll1) 2025-10-15T13:52Z XXX followers, XXX engagements


"$TECX Trades around cash. See below. Huge pullback from last secondary at $XXXXX per share. Still a binary event so position size is important. Im keeping position size small. Goal is to add post data if positive readout"  
[X Link](https://x.com/Pharmdca/status/1978107003810500660) [@Pharmdca](/creator/x/Pharmdca) 2025-10-14T14:33Z 109K followers, 5715 engagements


"Mizuho reiterated $TECX Outperform-$85 and said Tectonic will present Phase 1b (Part B) hemodynamic data for TX45 in pulmonary hypertension patients with HFrEF (PH-HFrEF) in early 4Q25. $MRK $AZN Mizuho added: We connected with Tectonic. Overall management expects the hemodynamic effects for TX45 in PH-HFrEF to move in the same direction as what was observed in patients with PH-HFpEF (Part A) where PCWP (left-sided filling pressure) mPAP PVR all declined meaningfully and cardiac output increased. KOLs we consulted also expect HFpEF and HFrEF patients to exhibit a similar pulmonary hemodynamic"  
[X Link](https://x.com/Quantumup1/status/1978055440534487279) [@Quantumup1](/creator/x/Quantumup1) 2025-10-14T11:09Z 3844 followers, 14.4K engagements